US Hematologist Compensation Reaches $446,700 in Doximity’s 2026 Report

nuaxia
vor 5 Tagen
3 Min. Lesezeit

Average annual compensation for US hematologists reached $446,700 in Doximity’s 2026 Physician Compensation Report, providing an updated national benchmark for physicians working in hematology.

US hematologists recorded average annual compensation of $446,700, according to Doximity’s 2026 Physician Compensation Report. The latest figure provides hematologists with a specialty-specific benchmark when evaluating their compensation, employment opportunities and the financial expectations associated with their practice.

Key findings

Doximity reports average annual compensation of $446,700 for hematologists in its 2026 Physician Compensation Report.

For hematologists, the figure provides a useful national reference point within a specialty encompassing the diagnosis, treatment and long-term management of malignant and non-malignant blood disorders.

The national average should not be interpreted as the compensation every hematologist will receive. Individual earnings can vary according to geography, experience, patient population, disease focus, clinical responsibilities, practice setting and employment structure.

Hematologist compensation reaches $446,700

The $446,700 average establishes a current national compensation benchmark for US hematologists.

Hematology encompasses a broad range of blood disorders, including anemia, bleeding and clotting disorders, hemoglobinopathies and hematologic malignancies such as leukemia, lymphoma and multiple myeloma.

Individual hematologists may concentrate on malignant hematology, non-malignant blood disorders, coagulation medicine or other areas of specialist practice. Some roles also combine hematology with medical oncology.

These differences can create substantially different patient populations, treatment responsibilities and workloads between individual hematology practices.

For hematologists reviewing their current compensation or considering a new position, the Doximity figure provides a useful specialty-specific reference against which an individual package can be assessed.

What influences hematologist compensation?

Hematology combines complex diagnostic work with longitudinal patient management, meaning patient volume, disease focus, treatment responsibilities and practice structure can all be important when evaluating individual compensation.

Hematologists treating patients with hematologic malignancies may have substantial responsibilities relating to systemic therapies, treatment monitoring, toxicity management and coordination with multidisciplinary cancer services.

Those specialising in non-malignant hematology may manage patients with complex bleeding, clotting, red blood cell and other chronic hematologic disorders requiring ongoing specialist assessment.

Geography, experience and employment model can further influence compensation. Hematologists may work within hospitals, academic medical centres, comprehensive cancer centres, health systems or specialist practices, with different organisations using different salary, productivity and incentive arrangements.

These factors mean the $446,700 national average should be treated as a benchmark rather than an expected salary for every hematologist.

What the latest figure means for hematologists

For US hematologists, $446,700 provides a contemporary national reference point when benchmarking existing compensation or assessing a prospective position.

When reviewing an employment opportunity, hematologists should consider headline compensation alongside expected patient volumes, disease focus, treatment responsibilities, working hours, call commitments and productivity requirements.

The precise nature of the hematology role is particularly important. A physician specialising in malignant hematology may have considerably different clinical responsibilities from one focused on non-malignant blood disorders or coagulation medicine.

The latest Doximity figure therefore provides hematologists with a useful starting point for evaluating compensation while recognising that individual earnings can differ substantially according to the clinical and contractual characteristics of a particular role.

About the data

The Doximity 2026 Physician Compensation Report provides compensation benchmarks across a wide range of US medical and surgical specialties.

The specialty figures represent average compensation and should be treated as national benchmarks. An individual hematologist’s compensation may differ according to geography, experience, patient population, disease focus, clinical responsibilities, practice setting and other professional factors.